DL
David Levi
Founder, Chief medical officer
Illumind therapeutics
I'm working on
5 months ago
Illumind Therapeutics is developing a novel neuroplasticity-based approach for PTSD using synergistic CNS therapeutics targeting glutamatergic dysfunction and maladaptive fear circuitry. Preparing for Phase 2 development and strategic partnerships.
I'm looking for
5 months ago
Strategic pharma partners, biotech investors, neuroscience advisors, clinical collaborators for clinical trial 2a, and non-dilutive funding opportunities to accelerate Phase 2 development in PTSD and neuropsychiatric disorders.
About
Illumind Therapeutics is a neuroscience-focused biotech advancing innovative treatments for PTSD and related disorders through targeted neuroplasticity and circuit-based therapeutic strategies. Our mission is to transform psychiatric care beyond symptom suppression toward durable functional recovery.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.